Answers are grounded in this paper and cite their sources.
Descriptive cross-sectional study found 11.5% tuberculosis prevalence in type 2 diabetics on insulin therapy, indicating rural residency and smoking as significant risk factors.
Background: Pulmonary tuberculosis continues to be a risky comorbidity among patients with type 2 diabetes mellitus, particularly those on long-term insulin therapy. Establishing the prevalence and risk factors of pulmonary tuberculosis in such individuals permits early prevention and detection, mostly in high-prevalence contexts. Objective: To determine the frequency of pulmonary tuberculosis in patients with type 2 diabetes on insulin therapy presenting to MMC Mardan. Study Design: Descriptive cross-sectional study. Duration and Place of Study: This study was conducted from January 2025 to May 2025, in the Department of Pulmonology, MTI-Mardan Medical Complex, Mardan. Methodology: A total of 113 patients aged 30–70 years with a diagnosis of T2DM on insulin therapy for at least 12 months were enrolled. Participants with at least two cardinal symptoms of tuberculosis underwent chest radiography followed by GeneXpert MTB/RIF assay for diagnostic confirmation. Results: The mean age was 49.23±11.61 years and the mean diabetes duration was 9.78±6.25 years. Overall frequency of pulmonary tuberculosis was 11.5% (n=13). Statistically significant associations were observed between PTB and rural residency (p<0.001), as well as smoking status (p<0.001). Conclusion: In our study, we concluded that pulmonary tuberculosis still poses a considerable risk among insulin-dependent type 2 diabetic individuals on insulin, particularly among rural residents and smokers.
No takes yet. Share an insight, caveat, or question.
Bahadur et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: